Dr. Pollack is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1520 9th Ave
Sacramento, CA 95818Phone+1 617-285-0866Fax+1 312-942-6216
Summary
- Dr. Mark Pollack is The Grainger Professor and Chairman of the Department of Psychiatry at Rush University Medical Center, and Director of the Road Home Program for Veterans and Their Families at Rush. He completed residency and fellowship training in psychiatry at Massachusetts General Hospital where he served as Director of the Center for Anxiety and Traumatic Stress Disorders and Professor of Psychiatry at Harvard Medical School until 2011.
His areas of clinical and research interest include the acute and long-term course, pathophysiology and treatment of patients with anxiety disorders and associated comorbidities, development of novel pharmacologic agents for mood and anxiety disorders, uses of combined cognitive-behavioral and pharmacologic therapies for treatment refractory patients and presentation and treatment of anxiety in the medical setting.
Dr Pollack has received federal funding from the National Institute of Mental Health (NIMH) and National Institute of Drug Abuse (NIDA) and has published over 500 articles, abstracts, reviews, chapters and books. He lectures widely in national and international forum and serves on numerous editorial and advisory boards. He is Past President and Chairman of the Scientific Advisory Board of the Anxiety and Depression Association of America and maintains an active consultative and clinical practice.
Education & Training
- Harvard UniversityM.A., with Honors, 2007
- Massachusetts General Hospital/McLean HospitalResidency, Psychiatry, 1982 - 1986
- Rutgers New Jersey Medical SchoolClass of 1982
- University of VirginiaB.A., 1978
Certifications & Licensure
- CA State Medical License 1987 - 2026
- CA State Medical License 1988 - 2024
- IL State Medical License 2011 - 2023
- MA State Medical License 1984 - 2013
- American Board of Psychiatry and Neurology Psychiatry
Awards, Honors, & Recognition
- Clinical Fellow ADAA, 2016
- Research Mentoring Program Mentor of the Year Rush University, 2015
- Excellence in Research Award Rush University Medical Center, 2015
- Join now to see all
Clinical Trials
- Eszopiclone for Sleep Disturbance and Nightmares in Post-Traumatic Stress Disorder Start of enrollment: 2005 Jun 01
- Improving Treatment Outcomes in Pharmacotherapy of Generalized Social Anxiety Disorder Start of enrollment: 2006 Mar 01
- Stress, Distress Intolerance, and Drug Dependence Start of enrollment: 2005 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- 141 citationsBrain connectomics predict response to treatment in social anxiety disorder.Susan Whitfield-Gabrieli, Satrajit S. Ghosh, Alfonso Nieto-Castanon, Zeynep M. Saygin, Oliver Doehrmann
Molecular Psychiatry. 2016-05-01 - 139 citationsA pilot study of vagus nerve stimulation (VNS) for treatment-resistant anxiety disorders.Mark S. George, Herbert E. Ward, Philip T. Ninan, Mark H. Pollack, Ziad Nahas
Brain Stimulation. 2008-04-01 - 33 citationsTwo weeks of pretreatment with escitalopram facilitates extinction learning in healthy individuals.Eric Bui, Scott P. Orr, Ryan J. Jacoby, Aparna Keshaviah, Nicole J. LeBlanc
Human Psychopharmacology. 2013-06-15
Journal Articles
- Examining the relationship between parent and child psychopathology in treatment-seeking veteransZalta AK, Bui E, Karnik NS, Held P, Laifer LM, Sager JC, Zou D, Rauch PK, Simon NM, Pollack MH, Ohye B, Child Psychiatry & Human Development, 1/1/2018
- Does D-cycloserine facilitate the effects of homework compliance on social anxiety symptom reduction?Roque A, Rosenfield D, Smits JAJ, Simon N, Otto MW, Marques L, Pollack MH, Hofmann SG, Meuret AE, Journal of Anxiety Disorders, 1/1/2018
- Characteristics of veterans and military service members who endorse causing harm, injury, or death to others in the militaryHeld P, Boley RA, Karnik NS, Pollack MH, Zalta AK, Psychological Trauma: Theory, Research, Practice, and Policy, 1/1/2018
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- The management of refractory anxiety disorders, OCD, and PTSD: An update.VanAmeringen M, Nemeroff CB, Pollack MH, Blair Simpson H, Perna G, Annual Meeting of the American Psychiatric Association, New York, NY, 1/1/2018
- Evaluating changes in sleep during a 3-week Intensive Outpatient Program for Veterans with PTSD.Wagner L, Zalta AK, Valdespino-Hayden Z, Burgess HJ, Boley RA, Held P, Pollack MH, ABCT�s 52nd Annual Confernce, Washington, DC, 1/1/2018
- Morally injurious events and veterans� social functioning: The role of anger as a mediator.Bravo K, Coleman J, Klassen B, Zalta A, Pollack M, Held P, International Society for Traumatic Stress Studies 34th Annual Meeting, Washington, DC, 1/1/2018
- Join now to see all
Lectures
- Novel approaches to the treatment of refractory anxietyUniversity of Texas Medical School, Galveston, TX - 1/1/2018
- Treatment of refractory social anxiety disorderNew York, NY, 2018; Washington, DC, 2018 - 1/1/2018
- GAD and panic disordersLas Vegas, NV - 1/1/2017
- Join now to see all
Other
- Coping with Anxiety.Pollack MH, Health Radio Network
1/1/2006 - Acute Stress Disorders in the Aftermath of Hurricane KatrinaPollack MH, Greater Boston PBS
1/1/2005 - Novel Approaches for Improving Outcomes in the Treatment of Anxiety.Pollack MH, Psychlink Satellite Broadcast
1/1/2005 - Join now to see all
Press Mentions
- Americans’ Anxiety Impacted by the Ongoing Pandemic, yet 1 in 5 Say They Won’t Seek Treatment According to the Genesight Mental Health Monitor Nationwide SurveyOctober 11th, 2021
- How to Convince Your Parents to Go to TherapyDecember 11th, 2020
- Nearly Two-Thirds of Older Adults Say They Won't Treat Their DepressionNovember 16th, 2020
- Join now to see all
Grant Support
- 3/3-Exposure D-Cycloserine Enhancement And Genetic Modulators In Panic DisorderNational Institute Of Mental Health2011–2012
- Eszopiclone For The Treatment Of PTSDNational Institute Of Mental Health2011
- 3/3-Exposure D-Cycloserine Enhancement And Genetic Modulators In Panic DisorderNational Institute Of Mental Health2008–2011
- D-Cycloserine Enhancement Of Exposure In Social PhobiaNational Institute Of Mental Health2007–2010
- Improving Outcomes In Pharmacotherapy Of Social PhobiaNational Institute Of Mental Health2005–2009
- Impact Of Trauma Of Terroist Attack On Bipolar PatientsNational Institute Of Mental Health2002–2003
- MR Spectroscopic Imaging During Methadone MaintenanceNational Institute On Drug Abuse1998–2002
- CBT For Illicit Drug Use In Methadone Treated PatientsNational Institute On Drug Abuse1995–1997
- Faculty Scholar Award In Depression And Anxiety (PsychiaCenter For Mental Health Services1992
- Faculty Scholar Award In Depression And Anxiety (PsychiaNational Institute Of Mental Health1991–1992
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: